Phase I Units
The facilities you need to make rapid “go/no-go” decisions.
Gain the critical data needed to make earlier, more confident decisions. Leave it to us to manage the complexity of Phase I trials in healthy volunteers, patients and special populations with our global network of clinical research units (CRUs).
A network of support
Drive your clinical research with our state-of-the-art CRUs backed up by a network of specialist site partners.
Get essential expertise
Leverage our in-house know-how as we manage the complexity of studies, react quickly to incoming data and speed toward an informed go/no-go decision.
On-site cGMP
Our on-site cGMP pharmacies simplify drug formulation and delivery.
Managing complexity is our specialty
Advance your Phase I trial at one of our four CRUs strategically based in the U.S. and the U.K. These state-of-the-art facilities provide everything you need to advance complex research while promoting participant well-being.
Leeds Drapers Yard, Reino Unido
Our sustainably designed CRU in Leeds Drapers Yard combines our two former locations with 100 beds, a cGMP pharmacy, including two sterile and two nonsterile rooms, and increased capacity for ECG and telemetry Holter monitoring.
Daytona Beach, Florida
Encompassing an estimated population of more than 21 million people, our Daytona Beach CRU boasts a track record of delivering on a range of trials spanning FIH bioequivalence, bioavailability, definitive QTc, drug-drug interaction, proof-of-concept, rising dose and Phase IIa patient studies.
Madison, Wisconsin
Our Madison CRU is regarded as the global leader in the conduct of radiolabeled clinical studies. The site also includes a cGMP pharmacy, including two sterile and three nonsterile manufacturing suites.
Dallas, Texas
With a dedicated ophthalmology suite and a cGMP pharmacy, including two sterile and three nonsterile manufacturing suites that can manage and handle high-potency and hazardous drugs, our Dallas CRU supports inpatient and outpatient Phase I-IV clinical trials of investigational medications.
The team had excellent communication and knowledge about what was always needed during the course of the study, and they were able to adapt to timelines as changes occurred.
Large Pharma
They were able to adapt to timelines.